investing-statsSEC Form 4 insider transactions

STE · STERIS plc

← all insiders

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Listed on NYSE

Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON

Open-market trades2
Distinct insiders2
Bought$0
Sold$1.25M
Net flow$-1.25M

Recent filings

How to read this

Filed
Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
Ticker
The issuer's stock symbol. Select it to open that company's insider-activity page.
Issuer
The company whose shares were traded.
Sector
The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
Insider
The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
Role
The insider's relationship to the company: director, officer, or 10% owner.
Code
SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
Side
Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
10b5-1
Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
Shares
Number of shares in this transaction.
Price
Reported price per share. Blank for grants, gifts, and other trades with no stated price.
Value
Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
Owned after
Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
Own Δ
How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
Co. Δ
Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
D/I
Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
Lag
Days from the trade date to the filing date (Form 4 is due within 2 business days).

Transaction codes

Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.

P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award or other acquisition pursuant to Rule 16b-3(d)
D
Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
M
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
G
Bona fide gift
C
Conversion of derivative security
X
Exercise of in-the-money or at-the-money derivative security
J
Other acquisition or disposition (describe transaction)
Recent Form 4 filings for STE
FiledDate the Form 4 was filed with the SEC (due within 2 business days of the trade).InsiderRoleCodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S).SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼).SharesNumber of shares in this transaction.PriceReported price per share. Blank for trades with no stated price.ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ).Owned afterShares the insider held (directly or indirectly) immediately after this trade.Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable.Link to SEC filing
2026-08-12Sohi MohsenDirectorM sell4,058 4,058 Ordinary Shares0filing
2026-08-12Sohi MohsenDirectorA buy1,229 1,229 Ordinary Shares8,979filing
2026-08-12Sohi MohsenDirectorA buy1,099 1,099 Ordinary Shares1,099filing
2026-08-12Sohi MohsenDirectorS sell4,0580$235.78$956.8K24,305−14%−<0.01% (now 0.02%)filing
2026-08-12Sohi MohsenDirectorM buy4,0580$86.23$349.9K28,363+17%+<0.01% (now 0.03%)filing
2026-08-12Shapiro LouisDirectorA buy1,025 1,025 Ordinary Shares2,000filing
2026-08-12Shah Nirav RDirectorA buy512 512 Ordinary Shares7,015filing
2026-08-12Shah Nirav RDirectorA buy1,506 1,506 Ordinary Shares1,506filing
2026-08-12Martin Paul EdwardDirectorA buy512 512 Ordinary Shares5,074filing
2026-08-12Martin Paul EdwardDirectorA buy1,506 1,506 Ordinary Shares1,506filing
2026-08-12HOLLAND CHRISTOPHER SDirectorA buy1,025 1,025 Ordinary Shares5,989filing
2026-08-12FELDMANN CYNTHIA LDirectorA buy512 512 Ordinary Shares8,640filing
2026-08-12FELDMANN CYNTHIA LDirectorA buy1,506 1,506 Ordinary Shares1,506filing
2026-08-12Boulud PierreDirectorA buy1,025 1,025 Ordinary Shares1,392filing
2026-08-12Alegria Esther M.DirectorA buy512 512 Ordinary Shares3,408filing
2026-08-12Alegria Esther M.DirectorA buy1,506 1,506 Ordinary Shares1,506filing
2026-07-02Sohi MohsenDirectorM sell3,781 3,781 Ordinary Shares0filing
2026-07-02Sohi MohsenDirectorF sell1,8370$212.30$390.0K24,305−7%−<0.01% (now 0.02%)filing
2026-07-02Sohi MohsenDirectorM buy3,7810$71.40$270.0K26,142+17%+<0.01% (now 0.03%)filing
2026-06-16Zangerle John AdamOfficer (Sr. VP, Gen Counsel, and Sec.)S sell10b5-11,4190$209.28$297.0K35,259−4%−<0.01% (now 0.04%)filing
2026-06-08Zangerle John AdamOfficer (Sr. VP, Gen Counsel, and Sec.)F sell4010$212.24$85.1K36,678−1%−<0.01% (now 0.04%)filing
2026-06-08Tamaro RenatoOfficer (V.P. & Corporate Treasurer)F sell650$212.24$13.8K6,194−1%−<0.01% (now <0.01%)filing
2026-06-08Madsen JuliaOfficer (Sr. VP and GM, Life Sciences)F sell1950$212.24$41.4K12,257−2%−<0.01% (now 0.01%)filing
2026-06-08Kohler Kenneth EOfficer (SVP & GM, AST)F sell1500$212.24$31.8K11,332−1%−<0.01% (now 0.01%)filing
2026-06-08Fraser Mary ClareOfficer (SVP & Chief HRO)F sell6000$212.24$127.3K13,716−4%−<0.01% (now 0.01%)filing
2026-06-08Carestio Daniel ADirector, Officer (President and CEO)S sell10b5-11,3740$212.00$291.3K63,647−2%−<0.01% (now 0.07%)filing
2026-06-08Carestio Daniel ADirector, Officer (President and CEO)S sell10b5-13,0540$214.64$655.5K65,021−4%−<0.01% (now 0.07%)filing
2026-06-08Carestio Daniel ADirector, Officer (President and CEO)F sell10b5-11,8890$212.24$400.9K68,075−3%−<0.01% (now 0.07%)filing
2026-06-08Burton Karen LOfficer (Sr. Vice Pres., CFO)F sell900$212.24$19.1K13,184−0.7%−<0.01% (now 0.01%)filing
2026-06-05Zangerle John AdamOfficer (Sr. VP, Gen Counsel, and Sec.)F sell3650$210.19$76.7K37,079−1.0%−<0.01% (now 0.04%)filing
2026-06-05Tamaro RenatoOfficer (V.P. & Corporate Treasurer)F sell640$210.19$13.5K6,259−1%−<0.01% (now <0.01%)filing
2026-06-05Madsen JuliaOfficer (Sr. VP and GM, Life Sciences)F sell2390$210.19$50.2K12,452−2%−<0.01% (now 0.01%)filing
2026-06-05Kohler Kenneth EOfficer (SVP & GM, AST)F sell1840$210.19$38.7K11,482−2%−<0.01% (now 0.01%)filing
2026-06-05Fraser Mary ClareOfficer (SVP & Chief HRO)F sell3110$210.19$65.4K14,316−2%−<0.01% (now 0.01%)filing
2026-06-05Carestio Daniel ADirector, Officer (President and CEO)F sell2,6190$210.19$550.5K69,964−4%−<0.01% (now 0.07%)filing
2026-06-05Burton Karen LOfficer (Sr. Vice Pres., CFO)F sell1900$210.19$39.9K13,274−1%−<0.01% (now 0.01%)filing
2026-06-04Zangerle John AdamOfficer (Sr. VP, Gen Counsel, and Sec.)A buy15,200 15,200 Ordinary Shares15,200filing
2026-06-04Zangerle John AdamOfficer (Sr. VP, Gen Counsel, and Sec.)F sell2470$209.76$51.8K37,444−0.7%−<0.01% (now 0.04%)filing
2026-06-04Zangerle John AdamOfficer (Sr. VP, Gen Counsel, and Sec.)A buy4,359037,691+13%+<0.01% (now 0.04%)filing
2026-06-04Tamaro RenatoOfficer (V.P. & Corporate Treasurer)A buy2,620 2,620 Ordinary Shares2,620filing
2026-06-04Tamaro RenatoOfficer (V.P. & Corporate Treasurer)F sell410$209.76$8.6K6,323−0.6%−<0.01% (now <0.01%)filing
2026-06-04Tamaro RenatoOfficer (V.P. & Corporate Treasurer)A buy75006,364+13%+<0.01% (now <0.01%)filing
2026-06-04McGowan LindseyOfficer (VP, Chf. Comp. & Quality Offc.)A buy4,036 4,036 Ordinary Shares4,036filing
2026-06-04McGowan LindseyOfficer (VP, Chf. Comp. & Quality Offc.)F sell3290$209.76$69.0K5,656−5%−<0.01% (now <0.01%)filing
2026-06-04McGowan LindseyOfficer (VP, Chf. Comp. & Quality Offc.)A buy1,15505,985+24%+<0.01% (now <0.01%)filing
2026-06-04Majors Cary LOfficer (SVP and President, Healthcare)A buy16,548 16,548 Ordinary Shares16,548filing
2026-06-04Majors Cary LOfficer (SVP and President, Healthcare)F sell670$209.76$14.1K17,338−0.4%−<0.01% (now 0.02%)filing
2026-06-04Majors Cary LOfficer (SVP and President, Healthcare)A buy4,746017,405+37%+<0.01% (now 0.02%)filing
2026-06-04Madsen JuliaOfficer (Sr. VP and GM, Life Sciences)A buy8,080 8,080 Ordinary Shares8,080filing
2026-06-04Madsen JuliaOfficer (Sr. VP and GM, Life Sciences)F sell1270$209.76$26.6K12,691−1.0%−<0.01% (now 0.01%)filing
2026-06-04Madsen JuliaOfficer (Sr. VP and GM, Life Sciences)A buy2,316012,818+22%+<0.01% (now 0.01%)filing
2026-06-04Kohler Kenneth EOfficer (SVP & GM, AST)A buy7,668 7,668 Ordinary Shares7,668filing
2026-06-04Kohler Kenneth EOfficer (SVP & GM, AST)F sell660$209.76$13.8K11,666−0.6%−<0.01% (now 0.01%)filing
2026-06-04Kohler Kenneth EOfficer (SVP & GM, AST)A buy2,199011,732+23%+<0.01% (now 0.01%)filing
2026-06-04Fraser Mary ClareOfficer (SVP & Chief HRO)A buy10,492 10,492 Ordinary Shares10,492filing
2026-06-04Fraser Mary ClareOfficer (SVP & Chief HRO)F sell5910$209.76$124.0K14,627−4%−<0.01% (now 0.02%)filing
2026-06-04Fraser Mary ClareOfficer (SVP & Chief HRO)A buy3,009015,218+25%+<0.01% (now 0.02%)filing
2026-06-04Carestio Daniel ADirector, Officer (President and CEO)A buy82,740 82,740 Ordinary Shares82,740filing
2026-06-04Carestio Daniel ADirector, Officer (President and CEO)F sell9950$209.76$208.7K72,583−1%−<0.01% (now 0.07%)filing
2026-06-04Carestio Daniel ADirector, Officer (President and CEO)A buy23,736073,578+48%+0.02% (now 0.08%)filing
2026-06-04Burton Karen LOfficer (Sr. Vice Pres., CFO)A buy18,564 18,564 Ordinary Shares18,564filing
2026-06-04Burton Karen LOfficer (Sr. Vice Pres., CFO)M sell660$209.76$13.8K13,464−0.5%−<0.01% (now 0.01%)filing
2026-06-04Burton Karen LOfficer (Sr. Vice Pres., CFO)A buy5,325013,530+65%+<0.01% (now 0.01%)filing
2026-06-04Breeden Richard CDirectorM sell3,781 3,781 Ordinary Shares0filing
2026-06-04Breeden Richard CDirectorS sell1,4810$209.51$310.3K38,964−4%−<0.01% (now 0.04%)filing
2026-06-04Breeden Richard CDirectorM buy3,7810$71.40$270.0K40,445+10%+<0.01% (now 0.04%)filing
2026-06-04Boulud PierreDirectorA buy367 367 Ordinary Shares367filing
2026-06-03Zangerle John AdamOfficer (Sr. VP, Gen Counsel, and Sec.)F sell337033,332−1%−<0.01% (now 0.03%)filing
2026-06-03Tamaro RenatoOfficer (V.P. & Corporate Treasurer)F sell8105,614−1%−<0.01% (now <0.01%)filing
2026-06-03McGowan LindseyOfficer (VP, Chf. Comp. & Quality Offc.)F sell19804,830−4%−<0.01% (now <0.01%)filing
2026-06-03Majors Cary LOfficer (SVP and President, Healthcare)F sell768012,659−6%−<0.01% (now 0.01%)filing
2026-06-03Madsen JuliaOfficer (Sr. VP and GM, Life Sciences)F sell208010,502−2%−<0.01% (now 0.01%)filing
2026-06-03Kohler Kenneth EOfficer (SVP & GM, AST)F sell10909,533−1%−<0.01% (now <0.01%)filing
2026-06-03Fraser Mary ClareOfficer (SVP & Chief HRO)F sell673012,209−5%−<0.01% (now 0.01%)filing
2026-06-03Carestio Daniel ADirector, Officer (President and CEO)F sell1,254049,842−2%−<0.01% (now 0.05%)filing
2026-06-03Burton Karen LOfficer (Sr. Vice Pres., CFO)F sell9908,205−1%−<0.01% (now <0.01%)filing

Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.